Jun 19, 2020
Global Market Outlook for Isopropanol (IPA) 2020-2029, with COVID-19 Adjusted Forecasts - ResearchAndMarkets.com
Jun 10, 2020
International Atherosclerosis Society Issues Call to Action to Improve Lipid Management Based on Survey Results to Address Patients' Residual Risk
Jun 08, 2020
Neurelis Announces Rapid and Broad Payer Coverage of the Company's Flagship Product, VALTOCO® (Diazepam Nasal Spray)
Jun 05, 2020
UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
May 26, 2020
DURECT Corporation Announces Positive Topline Data from Phase 1b Study of DUR-928 in NASH
May 15, 2020
Lipocine Announces Presentations on TLANDO(TM) at AUA Virtual Experience 2020
May 15, 2020
Studies Highlight Key Relationships Between Lifestyle, Sexual Health
May 14, 2020
Nitric Oxide Topical Serum Pilot Study for Aging Skin Published in Annals of Plastic and Reconstructive Surgery
May 14, 2020
Nobel Laureate, Dr. Ferid Murad, joins HumanN
May 13, 2020
Treatment Potential of LPCN 1144 Demonstrated in a Pre-Clinical NASH and Hepatic Fibrosis Model
May 12, 2020
Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP
May 04, 2020
Neurelis Announces That Intravail® Licensee, ARS Pharmaceuticals' Intranasal Epinephrine Product, Demonstrates Bioequivalent Exposure To Epinephrine Injectors
Apr 14, 2020
Oxea Increases n-propanol Availability in Europe for Disinfectant Manufacturers and the Printing Industry
Apr 09, 2020
Insights into the Worldwide Nitric Acid Market to 2027 - Growing Application of Polyurethane Foams Presents Lucrative Opportunities - ResearchAndMarkets.com
Apr 09, 2020
Natreon's exploratory study highlights benefits of a unique complex of trivalent chromium, shilajit and amla with fish-oil
Apr 07, 2020
Inhalation Anesthesia Market to Garner $1.54 Bn, Globally, by 2026 at 4.2% CAGR, Says Allied Market Research
Mar 31, 2020
2020 Zolpidem Market Study: Worldwide Trends & Developments, Major Players, Patents, and More
Mar 30, 2020
Regeneron Announces American College of Cardiology Presentation of Positive Phase 3 Evinacumab Results in Patients with Severe Inherited Form of High Cholesterol
Mar 28, 2020
Novartis new analysis further showed durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment
Mar 28, 2020
Amgen Announces Positive Results At ACC.20/WCC From Phase 3B Study Of Repatha® (Evolocumab) In People Living With HIV Who Have High LDL-Cholesterol